Building a New Innovation System: The Research and Education Side

2010 ◽  
pp. 188-233
2014 ◽  
Vol 20 (4) ◽  
pp. 601-623 ◽  
Author(s):  
Mansoureh Abdi ◽  
Alireza Hasanzadeh ◽  
Ali-Asghar Fani ◽  
Seyed Hassan Ghodsi Poor

This paper contributes to identify systematic problems in NIS using Thinking Process (TOC-TP) and to eliminate the bottlenecks, which results in improving the innovation process and efficiency of NIS. The Case study in this research is the NIS of Iran. The national documents of the innovation system were studied and all problems of NIS mentioned in documents were gathered. The causal relationships between the systematic problems were identified by the survey and grouped into 6 components by Exploratory Factor Analysis: weakness in technology diffusion mechanisms, the lack of centralized governance on science and technology policy, the government's pivotal role as an executor in education and research, weak laws and regulations in the field of research and technology, the lack of adequate financial resources in R&D and the lack of any perspective on the creation of wealth and entrepreneurship among the actors of research and technology. Finally the bottleneck of Iran's NIS was recognized by Thinking Process tools: the small participation of private sector in research and education system as the result of government's pivotal role as an executor of Iran's national innovation system. So the researchers could diagnose the policy gaps related to the identified bottlenecks.


Author(s):  
Per Levén

The chapter provides an integrated view of value creation in the development of new products and services related to ICT. The authors argue that innovation ecologies are key aspects for enhanced innovation processes. Building on early experiences from a project focused on the innovation ecologies of its wide range of R&D projects the authors ask how such a focus can help organizations utilize important resources in an open innovation system and guide universities – as driving engines in R&D activity systems – to become key players in open innovation systems and simultaneusly radically improve milieus for research and education. Exploring the outcome from the project and how customers are integrated into value creation processes during the course of design and use, we argue that innovation systems management and customer integration are important assets not only to increased efficiency and quality, but also for enhanced innovation. The authors coin the term ‘ecology of innovation’ to sum up the potentials related to innovation and value creation.


2006 ◽  
Vol 1 (4) ◽  
Author(s):  
Sudath Arumapperuma

The aim of this paper is to document agricultural innovation systems (AIS) in Australia. We identified eleven broad categories (actors) in terms of their activities, namely: policy, education, finance and credit, marketing, input supply, research, extension and information, logistics, processing and storage, farmers and farm organisations and consumers. Survey results reveal that 11 kinds of innovation-related activities of research and education organisations with corresponding percentage weight are directly involved in innovation diffusion. Twelve pre-identified goals of innovation related activities of the above organisations surveyed with their corresponding percentage weight have also been revealed. The study reveals that the majority of funding (more than 80%) for innovation activities comes from the Federal Government and funding bodies. Finally survey results indicate that the main constrains/incentives are other issues such as funding, lack of qualified staff, equipment, environmental and Government policy issues etc.


2020 ◽  
Vol 64 (6) ◽  
pp. 863-866
Author(s):  
Zhe Wu

Abstract The year 2019 marked the fortieth anniversary of the Chinese Society of Biochemistry and Molecular Biology (CSBMB), whose mission is to promote biomolecular research and education in China. The last 40 years have witnessed tremendous growth and achievements in biomolecular research by Chinese scientists and Essays in Biochemistry is delighted to publish this themed issue that focuses on exciting areas within RNA biology, with each review contributed by key experts from China.


1999 ◽  
Author(s):  
Amanda Griffiths ◽  
◽  
Curt Johansson ◽  
Clemens Weikert ◽  
Sten-Olof Brenner Brenner

2009 ◽  
Author(s):  
Brian Selmeski ◽  
Alan Okros ◽  
Rob Sands ◽  
Ed Wissian

2010 ◽  
Author(s):  
Maria R. Scharron-Del Rio ◽  
Florence Rubinson ◽  
Paul C. McCabe ◽  
Eliza A. Dragowski ◽  
Wayne Reed ◽  
...  

1983 ◽  
Vol 22 (03) ◽  
pp. 124-130 ◽  
Author(s):  
J. H. Bemmel

At first sight, the many applications of computers in medicine—from payroll and registration systems to computerized tomography, intensive care and diagnostics—do make a rather chaotic impression. The purpose of this article is to propose a scheme or working model for putting medical information systems in order. The model comprises six »levels of complexity«, running parallel to dependence on human interaction. Several examples are treated to illustrate the scheme. The reason why certain computer applications are more frequently used than others is analyzed. It has to be strongly considered that the differences in complexity and dependence on human involvement are not accidental but fundamental. This has consequences for research and education which are also discussed.


Author(s):  
Peter R. Breggin

BACKGROUND: The vaccine/autism controversy has caused vast scientific and public confusion, and it has set back research and education into genuine vaccine-induced neurological disorders. The great strawman of autism has been so emphasized by the vaccine industry that it, and it alone, often appears in authoritative discussions of adverse effects of the MMR and other vaccines. By dismissing the chimerical vaccine/autism controversy, vaccine defenders often dismiss all genuinely neurological aftereffects of the MMR (measles, mumps, and rubella) and other vaccines, including well-documented events, such as relatively rare cases of encephalopathy and encephalitis. OBJECTIVE: This report explains that autism is not a physical or neurological disorder. It is not caused by injury or disease of the brain. It is a developmental disorder that has no physical origins and no physical symptoms. It is extremely unlikely that vaccines are causing autism; but it is extremely likely that they are causing more neurological damage than currently appreciated, some of it resulting in psychosocial disabilities that can be confused with autism and other psychosocial disorders. This confusion between a developmental, psychosocial disorder and a physical neurological disease has played into the hands of interest groups who want to deny that vaccines have any neurological and associated neuropsychiatric effects. METHODS: A review of the scientific literature, textbooks, and related media commentary is integrated with basic clinical knowledge. RESULTS: This report shows how scientific sources have used the vaccine/autism controversy to avoid dealing with genuine neurological risks associated with vaccines and summarizes evidence that vaccines, including the MMR, can cause serious neurological disorders. Manufacturers have been allowed by the US Food and Drug Administration (FDA) to gain vaccine approval without placebo-controlled clinical trials. CONCLUSIONS: The misleading vaccine autism controversy must be set aside in favor of examining actual neurological harms associated with vaccines, including building on existing research that has been ignored. Manufacturers of vaccines must be required to conduct placebo-controlled clinical studies for existing vaccines and for government approval of new vaccines. Many probable or confirmed neurological adverse events occur within a few days or weeks after immunization and could be detected if the trials were sufficiently large. Contrary to current opinion, large, long-term placebo-controlled trials of existing and new vaccines would be relatively easy and safe to conduct.


Sign in / Sign up

Export Citation Format

Share Document